Cargando…

microRNA-122 Abundance in Hepatocellular Carcinoma and Non-Tumor Liver Tissue from Japanese Patients with Persistent HCV versus HBV Infection

Mechanisms of hepatic carcinogenesis in chronic hepatitis B and hepatitis C are incompletely defined but often assumed to be similar and related to immune-mediated inflammation. Despite this, several studies hint at differences in expression of miR-122, a liver-specific microRNA with tumor suppresso...

Descripción completa

Detalles Bibliográficos
Autores principales:	Spaniel, Carolyn, Honda, Masao, Selitsky, Sara R., Yamane, Daisuke, Shimakami, Tetsuro, Kaneko, Shuichi, Lanford, Robert E., Lemon, Stanley M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3793926/ https://www.ncbi.nlm.nih.gov/pubmed/24130799 http://dx.doi.org/10.1371/journal.pone.0076867

Ejemplares similares

Differential hepatitis C virus RNA target site selection and host factor activities of naturally occurring miR-122 3΄ variants
por: Yamane, Daisuke, et al.
Publicado: (2017)

Small tRNA-derived RNAs are increased and more abundant than microRNAs in chronic hepatitis B and C
por: Selitsky, Sara R., et al.
Publicado: (2015)

The Acyclic Retinoid Peretinoin Inhibits Hepatitis C Virus Replication and Infectious Virus Release in Vitro
por: Shimakami, Tetsuro, et al.
Publicado: (2014)

Efficient Suppression of Hepatitis C Virus Replication by Combination Treatment with miR-122 Antagonism and Direct-acting Antivirals in Cell Culture Systems
por: Liu, Fanwei, et al.
Publicado: (2016)

The osteopontin-CD44 axis in hepatic cancer stem cells regulates IFN signaling and HCV replication
por: Shirasaki, Takayoshi, et al.
Publicado: (2018)

Hepatitis B virus X protein induces hepatic stem cell-like features in hepatocellular carcinoma by activating KDM5B
por: Wang, Xuyang, et al.
Publicado: (2017)

Characterization of miR-122-independent propagation of HCV
por: Ono, Chikako, et al.
Publicado: (2017)

Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV
por: Tseng, Chih-Wei, et al.
Publicado: (2022)

Transcriptomic Analysis of Chronic Hepatitis B and C and Liver Cancer Reveals MicroRNA-Mediated Control of Cholesterol Synthesis Programs
por: Selitsky, Sara R., et al.
Publicado: (2015)

Disruption of TLR3 Signaling Due to Cleavage of TRIF by the Hepatitis A Virus Protease-Polymerase Processing Intermediate, 3CD
por: Qu, Lin, et al.
Publicado: (2011)

HBV and HCV Therapy
por: Lampertico, Pietro, et al.
Publicado: (2009)

miR-122 Stimulates Hepatitis C Virus RNA Synthesis by Altering the Balance of Viral RNAs Engaged in Replication versus Translation
por: Masaki, Takahiro, et al.
Publicado: (2015)

Peretinoin, an Acyclic Retinoid, Inhibits Hepatitis B Virus Replication by Suppressing Sphingosine Metabolic Pathway In Vitro
por: Murai, Kazuhisa, et al.
Publicado: (2018)

Establishment of liver tumor cell lines from atherogenic and high fat diet fed hepatitis C virus transgenic mice
por: Shirasaki, Takayoshi, et al.
Publicado: (2021)

Identification of a Transmembrane Protein Involved in Shear Stress Signaling and Hepatocarcinogenesis After a Sustained Virological Response to Hepatitis C Virus
por: Nishikawa, Masashi, et al.
Publicado: (2023)

HBV and HCV Infection in Children and Adolescents
por: Pokorska-Śpiewak, Maria, et al.
Publicado: (2023)

Role of miR-122 and lipid metabolism in HCV infection
por: Fukuhara, Takasuke, et al.
Publicado: (2012)

MicroRNA-122 Regulation of HCV Infections: Insights from Studies of miR-122-Independent Replication
por: Panigrahi, Mamata, et al.
Publicado: (2022)

Preexisting Humoral Immunity Cross-Reacting with SARS-CoV-2 Might Prevent Death Due to COVID-19 in Critical Patients
por: Yamashita, Taro, et al.
Publicado: (2022)

Alterations in Hepatocellular Carcinoma-Specific Immune Responses Following Hepatitis C Virus Elimination by Direct-Acting Antivirals
por: Li, Shihui, et al.
Publicado: (2022)

Super-Resolution Microscopy Analysis of Hepatitis B Viral cccDNA and Host Factors
por: Doan, Phuong Thi Bich, et al.
Publicado: (2023)

HBV and HCV genotypes distribution on the territory of Belarus
por: Gasich, EL, et al.
Publicado: (2012)

Editorial: Recent Advances in HBV and HCV Immunology
por: Dustin, Lynn B., et al.
Publicado: (2015)

Therapeutic vaccines in HBV: lessons from HCV
por: Barnes, Eleanor
Publicado: (2015)

The Chimpanzee Model of Viral Hepatitis: Advances in Understanding the Immune Response and Treatment of Viral Hepatitis
por: Lanford, Robert E, et al.
Publicado: (2017)

Correlation of serum microRNA-122 level with the levels of Alanine aminotransferase and HBV-DNA in Chronic HBV-infected patients
por: Tabar Asad Laleh, Rana, et al.
Publicado: (2021)

Notch signaling facilitates hepatitis B virus covalently closed circular DNA transcription via cAMP response element-binding protein with E3 ubiquitin ligase-modulation
por: Wang, Zijing, et al.
Publicado: (2019)

Peretinoin, an acyclic retinoid, suppresses steatohepatitis and tumorigenesis by activating autophagy in mice fed an atherogenic high-fat diet
por: Okada, Hikari, et al.
Publicado: (2017)

HBV/HCV dual infection impacts viral load, antibody response, and cytokine expression differently from HBV or HCV single infection
por: Chen, Fei, et al.
Publicado: (2016)

Kinetics of miR-122 Expression in the Liver during Acute HCV Infection
por: Choi, Youkyung, et al.
Publicado: (2013)

Various miRNAs compensate the role of miR-122 on HCV replication
por: Ono, Chikako, et al.
Publicado: (2020)

Heme and HO-1 Inhibition of HCV, HBV, and HIV
por: Schmidt, Warren N., et al.
Publicado: (2012)

Prevalence of HBV and HCV among blood donors in Kosovo
por: Fejza, Hajrullah, et al.
Publicado: (2009)

HIV, HCV and HBV: A Review of Parallels and Differences
por: Leoni, Maria C., et al.
Publicado: (2018)

Hurdles to the Development of Effective HBV Immunotherapies and HCV Vaccines
por: Torres-Cornejo, Almudena, et al.
Publicado: (2017)

Establishment and Characterization of a New Cell Line Permissive for Hepatitis C Virus Infection
por: Omura, Hitoshi, et al.
Publicado: (2019)

FOXM1 Is a Novel Molecular Target of AFP-Positive Hepatocellular Carcinoma Abrogated by Proteasome Inhibition
por: Li, Ru, et al.
Publicado: (2022)

Circulating Interferon-λ3, Responsiveness to HBV Vaccination, and HBV/HCV Infections in Haemodialysis Patients
por: Grzegorzewska, Alicja E., et al.
Publicado: (2017)

The Role of the Liver-Specific microRNA, miRNA-122 in the HCV Replication Cycle
por: Kunden, Rasika D., et al.
Publicado: (2020)

Circulating microRNA-122 in HCV cirrhotic patients with high frequency of genotype 3
por: Ullah, Amin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vv5fcckoucd3vsr6cq6pmaifn4